22 results
8-K
PRAX
Praxis Precision Medicines Inc
11 May 23
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2023 Financial Results
7:31am
, the Company announced positive topline results from the PRAX-628 Phase 1 healthy volunteer study evaluating the safety, tolerability
8-K
EX-99.1
PRAX
Praxis Precision Medicines Inc
11 May 23
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2023 Financial Results
7:31am
event (details to follow)
In May 2023, Praxis announced positive topline results from a Phase 1 healthy volunteer study of PRAX-628 evaluating
8-K
EX-99.1
PRAX
Praxis Precision Medicines Inc
9 Nov 22
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:03pm
in 2023
PRAX-628 Phase 1 healthy volunteer study to initiate in 4Q22; focal epilepsy study planned for 2023
Cash and investments of $123.7 million
8-K
EX-99.2
b5khpyyutnw9o v1v
3 Nov 21
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2021 Financial Results
7:04am
8-K
EX-99.1
xi5tg8hezot 4uz
3 Nov 21
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2021 Financial Results
7:04am
8-K
EX-99.1
397d qw9xwbq
16 Aug 21
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2021 Financial Results
8:04am
424B4
5jp qpzqz
14 May 21
Prospectus supplement with pricing info
4:34pm
8-K
EX-99.2
w5zaqav 4y79mhjx2nt
11 May 21
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2021 Financial Results
8:11am
DRS
oa3hl5act4h
18 Mar 21
Draft registration statement
12:00am
10-K
zb1bpc
17 Mar 21
Annual report
8:33am
8-K
EX-99.1
1eolmm9yw4srqvdgpi
17 Mar 21
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
7:17am
424B4
a7tj xsuq
16 Oct 20
Prospectus supplement with pricing info
4:02pm
S-1
c6epm2t 6dpzg9qij16
25 Sep 20
IPO registration
5:19pm